Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

ESMO Open · 2026 · PMC13273794 · PMID 42269232

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Notably, patients with PR/CR to induction showed a trend toward improved OS irrespective of the de-intensification strategy ( Supplementary Figure S3 , available at https://doi.org/10.1016/j.esmoop.2026.107775 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.